INVEX Therapeutics Ltd (ixc) Logo

INVEX Therapeutics Ltd (IXC)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

Financials

06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profitability
NPAT ($) (3,360,279) - - - - - - - - -
NPAT Margin -- -- - - - - - - - -
Return on Equity (ROE) -13.29% 0.00% - - - - - - - -
Return on Assets (ROA) -12.27% 0.00% - - - - - - - -
Valuation
PE Ratio (22.53) 0.00 - - - - - - - -
PE Relative to Market 0.0% -- - - - - - - - -
Price to Book 3.60 0.00 - - - - - - - -
Price to Cash Flow (36.78) 0.00 - - - - - - - -
Shares Outstanding (M) 67.50 31.25 - - - - - - - -
Market Cap ($M) $87.75 $0.00 - - - - - - - -
Enterprise Value ($M) $61.45 $-12.17 - - - - - - - -
Performance
Total Shareholder Return 0.0% -- - - - - - - - -
Relative to Market 0.0% -- - - - - - - - -
Per Share
Earnings (5.77) 0.00 - - - - - - - -
Cash Flow (2.90) 0.00 - - - - - - - -
Cash 0.39 0.39 - - - - - - - -
Net Tangible Assets 0.36 0.37 - - - - - - - -
Book Value 0.36 0.37 - - - - - - - -
Share Price $1.30 $0.00 - - - - - - - -
Liquidity
Quick Ratio 13.11 13.17 - - - - - - - -
Current Ratio 13.11 13.17 - - - - - - - -
Efficiency
Asset Turnover 0.00 0.00 - - - - - - - -
Inventory Turnover - - - - - - - - - -
Working Capital Turnover 0.00 0.00 - - - - - - - -
Dividends
DPS (c) - - - - - - - - - -
Dividend yield - - - - - - - - - -
Franking - - - - - - - - - -
Gross DPS (c) - - - - - - - - - -
Gross Dividend Yield - - - - - - - - - -
Payout Ratio - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
INCOME
Trading Revenue - - - - - - - - - -
Other Income - - - - - - - - - -
Total Income Excl. Interest - - - - - - - - - -
INTEREST/FINANCE INCOME
Forex Gain/Loss - - - - - - - - - -
Total Income - - - - - - - - - -
EXPENSES
Expenses (3,408,036) - - - - - - - - -
EBITDA (3,408,036) - - - - - - - - -
DEPRECIATION AND AMORTISATION
Depreciation - - - - - - - - - -
Amortisation - - - - - - - - - -
Depreciation & Amortisation - - - - - - - - - -
EBIT (3,408,036) - - - - - - - - -
INTEREST/FINANCE EXPENSES
Interest/Finance Income 165,703 - - - - - - - - -
Interest Expense - - - - - - - - - -
Interest Capitalised - - - - - - - - - -
Interest Expenses Incl. Capital - - - - - - - - - -
Net Interest Expenses 165,703 - - - - - - - - -
Pre-Tax Profit (3,242,333) - - - - - - - - -
Net Capital Profits - - - - - - - - - -
Pre-Tax Profit Pre-Cap (3,242,333) - - - - - - - - -
TAX
Tax Expenses - - - - - - - - - -
NPAT before Abnormals (3,242,333) - - - - - - - - -
ABNORMALS
Abnormals (117,946) - - - - - - - - -
Abnormals Tax - - - - - - - - - -
Net Abnormals (117,946) - - - - - - - - -
Non-Controlling Interests - - - - - - - - - -
Reported NPAT after Abnormals (3,360,279) - - - - - - - - -
NPAT before Capital (3,360,279) - - - - - - - - -
EQUITY
Diluted Shares 67,500,001 31,249,988 - - - - - - - -
Diluted Weighted Shares 56,165,385 31,249,988 - - - - - - - -
Ordinary Dividends - - - - - - - - - -
Preference Dividends - - - - - - - - - -
EPS Adjusted (57,700) - - - - - - - - -
EPS after Abnormals (59,828) - - - - - - - - -
Share of net Profit/Loss - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Assets
Cash 26,300,459 12,170,247 - - - - - - - -
Receivables 116,882 83,330 - - - - - - - -
Prepayments - - - - - - - - - -
Inventories - - - - - - - - - -
Investments - - - - - - - - - -
Other - - - - - - - - - -
Total Current Assets 26,417,341 12,253,577 - - - - - - - -
Non-current assets
Receivables - - - - - - - - - -
Inventories - - - - - - - - - -
PP&E - - - - - - - - - -
Investments - - - - - - - - - -
Intangibles Excl. Goodwill - - - - - - - - - -
Goodwill - - - - - - - - - -
Future Income Tax Benefit - - - - - - - - - -
Other - 117,946 - - - - - - - -
Total Non-Current Assets - 117,946 - - - - - - - -
Total Assets 26,417,341 12,371,523 - - - - - - - -
Current Liabilities
Accounts Payable 712,946 930,295 - - - - - - - -
Provisions - - - - - - - - - -
Short Term Debt - - - - - - - - - -
Other 1,302,427 - - - - - - - - -
Total Current Liabilities 2,015,373 930,295 - - - - - - - -
Non-current liabilities
Accounts Payable - - - - - - - - - -
Long Term Debt - - - - - - - - - -
Provisions - - - - - - - - - -
Other - - - - - - - - - -
Total Non-Current Liabilities - - - - - - - - - -
Total Liabilities 2,015,373 930,295 - - - - - - - -
Shareholder Equity
Share Capital 27,017,127 11,692,615 - - - - - - - -
Convertible Equity - - - - - - - - - -
Other Equity - - - - - - - - - -
Reserves ex. Share Premium 977,242 - - - - - - - - -
Share Premium Reserves - - - - - - - - - -
Retained Profits (3,592,401) (251,387) - - - - - - - -
Total Available Equity Assets 24,400,000 - - - - - - - - -
External Equity
Non-controlling Interests - - - - - - - - - -
Net Assets 24,401,968 11,441,228 - - - - - - - -
Total Debt - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
OPERATING ACTIVITIES
Receipts - - - - - - - - - -
Payments (1,769,096) - - - - - - - - -
Dividends Received - - - - - - - - - -
Interest Received 165,703 - - - - - - - - -
Interest Paid - - - - - - - - - -
Taxes Paid - - - - - - - - - -
Other - - - - - - - - - -
Net Operating Cash Flow (1,603,393) - - - - - - - - -
INVESTMENT ACTIVITIES
Capital Expend. Excl. Investments - - - - - - - - - -
Payments for Investment - - - - - - - - - -
Payments for Subsidiaries - - - - - - - - - -
Proceeds from PP&E - - - - - - - - - -
Proceeds from Investments - - - - - - - - - -
Proceeds from Subsidiaries - - - - - - - - - -
Loans Granted - - - - - - - - - -
Loans Repaid - - - - - - - - - -
Other Investments - - - - - - - - - -
Net Investment Cash Flow - - - - - - - - - -
Operating CF less Investment CF (1,603,393) - - - - - - - - -
FINANCING ACTIVITIES
Proceeds from Issues 16,250,125 - - - - - - - - -
Proceeds from Borrowings - - - - - - - - - -
Repayment of Borrowings - - - - - - - - - -
Dividends Paid - - - - - - - - - -
Other Financing Activities (516,520) - - - - - - - - -
Net Financing Cash Flow 15,733,605 - - - - - - - - -
Total Net Cashflow 14,130,212 - - - - - - - - -
CASH
Cash and Cash Equiv. Period Open 12,170,247 - - - - - - - - -
Exchange Rate Adjustments - - - - - - - - - -
Other Cash Adjustments - - - - - - - - - -
Cash and Cash Equiv. Period Close 26,300,459 - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo